Skip to main content

Response to: “Public Health Dilemmas Concerning a Two-year-old Hepatitis-B Carrier”

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Oon, C. J., Chen, W. N., Goo, K. S., & Goh, K. T. (2000). Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. Journal of Infection, 41(3), 260–264.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Hsu, H. Y., Chang, M., Ni, Y. H., Lin, H. H., Wang, S. M., & Chen, D. S. (1997). Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology, 26(3), 786–791.

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Ogata, N., Cote, P. J., Zanetti, A. R., Miller, R. H., Shapiro, M., Gerin, J., et al. (1999). Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology, 30(3), 779–786.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Boot, H. (2007). Hepatitis B-vaccinie is ook effectief tegen de G145R-mutant. [Hepatitis B vaccination is also effective against G145R-mutant]. Infectieziektenbulletin, 18(6), 215–216.

    Google Scholar 

  5. 5.

    Zuckerman, A. J. (2000). Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet, 355, 1382–1384.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Tabor, E. (2006). Infections by hepatitis B surface antigen gene mutants in Europe and North America. Journal of Medical Virology, 78(Suppl), S43–S47.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to R. Batey.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Batey, R. Response to: “Public Health Dilemmas Concerning a Two-year-old Hepatitis-B Carrier”. Bioethical Inquiry 5, 83–84 (2008). https://doi.org/10.1007/s11673-008-9080-y

Download citation

Keywords

  • Mutant Form
  • Public Health Service
  • Ideal World
  • Routine Vaccination
  • Vaccine Protection